morphine sulfate in 0.9% Sodium Chloride injectable, 1 mg per mL, Total Volume 100 mL, Single Dos...
FDA Drug Recall #D-0870-2017 — Class II — May 18, 2017
Recall Summary
| Recall Number | D-0870-2017 |
| Classification | Class II — Moderate risk |
| Date Initiated | May 18, 2017 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | SCA Pharmaceuticals |
| Location | Little Rock, AR |
| Product Type | Drugs |
| Quantity | 80 bags |
Product Description
morphine sulfate in 0.9% Sodium Chloride injectable, 1 mg per mL, Total Volume 100 mL, Single Dose Container bag, (Total morphine Dose 100 mg/ 100mL), Preservative Free (Contains Sulfites), Rx only, SCA Pharmaceuticals, 8821 Knoedl Ct, Little Rock, AR 72205, NDC 70004-0100-32.
Reason for Recall
Lack of assurance of sterility: Product bags leaking at seam.
Distribution Pattern
Nationwide in the USA
Lot / Code Information
LOT # 20170508@57, Use By: 08/06/17
Other Recalls from SCA Pharmaceuticals
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0945-2023 | Class II | FentaNYL 500 mcg/250 mL - Bupivacaine HCl 0.1% ... | Jul 20, 2023 |
| D-0555-2023 | Class III | Oxytocin 30 units added to 0.9% Sodium Chloride... | Apr 10, 2023 |
| D-0363-2023 | Class III | Fentanyl 1,500 mcg/30 mL syringe, Injection for... | Feb 24, 2023 |
| D-0829-2022 | Class II | Norepinephrine 8mg in 0.9% Sodium Chloride 250 ... | Apr 25, 2022 |
| D-0831-2022 | Class II | Vancomycin HCl 1.5 g in 0.9% Sodium Chloride, 5... | Apr 25, 2022 |
Frequently Asked Questions
Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.